Report Detail
Global Tuberculosis Diagnostics Market Insights, Forecast to 2025
- RnM2937591 |
- 13 February, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Other
The global Tuberculosis Diagnostics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tuberculosis Diagnostics market based on company, product type, end user and key regions.
This report studies the global market size of Tuberculosis Diagnostics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tuberculosis Diagnostics in these regions.
This research report categorizes the global Tuberculosis Diagnostics market by top players/brands, region, type and end user. This report also studies the global Tuberculosis Diagnostics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories
Becton, Dickinson and Company
Alere, Inc.
BioMerieux SA
F.Hoffmann-La Roche AG
Thermo Fisher Scientific
Siemens
Cepheid
Akonni Biosystems
Hain Lifesciences GmBH
NanoEnTe
Hologic Corporation
Market size by Product
Smear Microscopy
LF-LAM For PLHIV
Culture
Molecular Testing
Drug Susceptibility Testing
Mantoux Tuberculin Testing
Market size by End User
Hospital
Diagnostic laboratories
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Tuberculosis Diagnostics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Tuberculosis Diagnostics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tuberculosis Diagnostics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Tuberculosis Diagnostics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Tuberculosis Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tuberculosis Diagnostics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Tuberculosis Diagnostics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Tuberculosis Diagnostics Market Size Growth Rate by Product
- 1.4.2 Smear Microscopy
- 1.4.3 LF-LAM For PLHIV
- 1.4.4 Culture
- 1.4.5 Molecular Testing
- 1.4.6 Drug Susceptibility Testing
- 1.4.7 Mantoux Tuberculin Testing
- 1.5 Market by End User
- 1.5.1 Global Tuberculosis Diagnostics Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Diagnostic laboratories
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Tuberculosis Diagnostics Market Size
- 2.1.1 Global Tuberculosis Diagnostics Revenue 2014-2025
- 2.1.2 Global Tuberculosis Diagnostics Sales 2014-2025
- 2.2 Tuberculosis Diagnostics Growth Rate by Regions
- 2.2.1 Global Tuberculosis Diagnostics Sales by Regions
- 2.2.2 Global Tuberculosis Diagnostics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Tuberculosis Diagnostics Sales by Manufacturers
- 3.1.1 Tuberculosis Diagnostics Sales by Manufacturers
- 3.1.2 Tuberculosis Diagnostics Sales Market Share by Manufacturers
- 3.1.3 Global Tuberculosis Diagnostics Market Concentration Ratio (CR5 and HHI)
- 3.2 Tuberculosis Diagnostics Revenue by Manufacturers
- 3.2.1 Tuberculosis Diagnostics Revenue by Manufacturers (2014-2019)
- 3.2.2 Tuberculosis Diagnostics Revenue Share by Manufacturers (2014-2019)
- 3.3 Tuberculosis Diagnostics Price by Manufacturers
- 3.4 Tuberculosis Diagnostics Manufacturing Base Distribution, Product Types
- 3.4.1 Tuberculosis Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Tuberculosis Diagnostics Product Type
- 3.4.3 Date of International Manufacturers Enter into Tuberculosis Diagnostics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Tuberculosis Diagnostics Sales by Product
- 4.2 Global Tuberculosis Diagnostics Revenue by Product
- 4.3 Tuberculosis Diagnostics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Tuberculosis Diagnostics Breakdown Data by End User
6 North America
- 6.1 North America Tuberculosis Diagnostics by Countries
- 6.1.1 North America Tuberculosis Diagnostics Sales by Countries
- 6.1.2 North America Tuberculosis Diagnostics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Tuberculosis Diagnostics by Product
- 6.3 North America Tuberculosis Diagnostics by End User
7 Europe
- 7.1 Europe Tuberculosis Diagnostics by Countries
- 7.1.1 Europe Tuberculosis Diagnostics Sales by Countries
- 7.1.2 Europe Tuberculosis Diagnostics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Tuberculosis Diagnostics by Product
- 7.3 Europe Tuberculosis Diagnostics by End User
8 Asia Pacific
- 8.1 Asia Pacific Tuberculosis Diagnostics by Countries
- 8.1.1 Asia Pacific Tuberculosis Diagnostics Sales by Countries
- 8.1.2 Asia Pacific Tuberculosis Diagnostics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Tuberculosis Diagnostics by Product
- 8.3 Asia Pacific Tuberculosis Diagnostics by End User
9 Central & South America
- 9.1 Central & South America Tuberculosis Diagnostics by Countries
- 9.1.1 Central & South America Tuberculosis Diagnostics Sales by Countries
- 9.1.2 Central & South America Tuberculosis Diagnostics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Tuberculosis Diagnostics by Product
- 9.3 Central & South America Tuberculosis Diagnostics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Tuberculosis Diagnostics by Countries
- 10.1.1 Middle East and Africa Tuberculosis Diagnostics Sales by Countries
- 10.1.2 Middle East and Africa Tuberculosis Diagnostics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Tuberculosis Diagnostics by Product
- 10.3 Middle East and Africa Tuberculosis Diagnostics by End User
11 Company Profiles
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Abbott Laboratories Tuberculosis Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Abbott Laboratories Tuberculosis Diagnostics Products Offered
- 11.1.5 Abbott Laboratories Recent Development
- 11.2 Becton, Dickinson and Company
- 11.2.1 Becton, Dickinson and Company Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Becton, Dickinson and Company Tuberculosis Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Becton, Dickinson and Company Tuberculosis Diagnostics Products Offered
- 11.2.5 Becton, Dickinson and Company Recent Development
- 11.3 Alere, Inc.
- 11.3.1 Alere, Inc. Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Alere, Inc. Tuberculosis Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Alere, Inc. Tuberculosis Diagnostics Products Offered
- 11.3.5 Alere, Inc. Recent Development
- 11.4 BioMerieux SA
- 11.4.1 BioMerieux SA Company Details
- 11.4.2 Company Business Overview
- 11.4.3 BioMerieux SA Tuberculosis Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 BioMerieux SA Tuberculosis Diagnostics Products Offered
- 11.4.5 BioMerieux SA Recent Development
- 11.5 F.Hoffmann-La Roche AG
- 11.5.1 F.Hoffmann-La Roche AG Company Details
- 11.5.2 Company Business Overview
- 11.5.3 F.Hoffmann-La Roche AG Tuberculosis Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 F.Hoffmann-La Roche AG Tuberculosis Diagnostics Products Offered
- 11.5.5 F.Hoffmann-La Roche AG Recent Development
- 11.6 Thermo Fisher Scientific
- 11.6.1 Thermo Fisher Scientific Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Thermo Fisher Scientific Tuberculosis Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Thermo Fisher Scientific Tuberculosis Diagnostics Products Offered
- 11.6.5 Thermo Fisher Scientific Recent Development
- 11.7 Siemens
- 11.7.1 Siemens Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Siemens Tuberculosis Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Siemens Tuberculosis Diagnostics Products Offered
- 11.7.5 Siemens Recent Development
- 11.8 Cepheid
- 11.8.1 Cepheid Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Cepheid Tuberculosis Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Cepheid Tuberculosis Diagnostics Products Offered
- 11.8.5 Cepheid Recent Development
- 11.9 Akonni Biosystems
- 11.9.1 Akonni Biosystems Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Akonni Biosystems Tuberculosis Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Akonni Biosystems Tuberculosis Diagnostics Products Offered
- 11.9.5 Akonni Biosystems Recent Development
- 11.10 Hain Lifesciences GmBH
- 11.10.1 Hain Lifesciences GmBH Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Hain Lifesciences GmBH Tuberculosis Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Hain Lifesciences GmBH Tuberculosis Diagnostics Products Offered
- 11.10.5 Hain Lifesciences GmBH Recent Development
- 11.11 NanoEnTe
- 11.12 Hologic Corporation
12 Future Forecast
- 12.1 Tuberculosis Diagnostics Market Forecast by Regions
- 12.1.1 Global Tuberculosis Diagnostics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Tuberculosis Diagnostics Revenue Forecast by Regions 2019-2025
- 12.2 Tuberculosis Diagnostics Market Forecast by Product
- 12.2.1 Global Tuberculosis Diagnostics Sales Forecast by Product 2019-2025
- 12.2.2 Global Tuberculosis Diagnostics Revenue Forecast by Product 2019-2025
- 12.3 Tuberculosis Diagnostics Market Forecast by End User
- 12.4 North America Tuberculosis Diagnostics Forecast
- 12.5 Europe Tuberculosis Diagnostics Forecast
- 12.6 Asia Pacific Tuberculosis Diagnostics Forecast
- 12.7 Central & South America Tuberculosis Diagnostics Forecast
- 12.8 Middle East and Africa Tuberculosis Diagnostics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Tuberculosis Diagnostics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Tuberculosis Diagnostics . Industry analysis & Market Report on Tuberculosis Diagnostics is a syndicated market report, published as Global Tuberculosis Diagnostics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Tuberculosis Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
